Management Team

Thomas J. Meade, Ph.D., Founder, is the Eileen M. Foell Professor of Chemistry, Biochemistry and Molecular and Cell Biology, Neurobiology and Physiology and Radiology at Northwestern University.  He has founded three successful start-up companies based on his research at the California Institute of Technology and Northwestern University:  Clinical Micro Sensors (CMS) which is developing electrochemical sensors for the detection of nucleic acids, Metaprobe which has focused on in vivo biochemically-activated magnetic resonance contrast agents, and PreDx, a company also focused on imaging technologies.  CMS was acquired by Motorola in 2000 for $300 million.  Dr. Meade is currently the inventor on more than 70 patents and patent applications, including those that Ohmx has licensed from CMS and Northwestern University.

Barbara Beug Dyson, Chairman of the Board of Directors, is a Founder and Principal of Dyson, Dyson & Dunn, Inc., a private equity firm focused on middle market industrial manufacturing, distribution and service companies. Ms. Dyson's firm owns and operates eight companies with sales of over $200 million. Ms. Dyson received her B.S. in Economics from Rollins College and has an M.B.A. from Northwestern University's Kellogg School of Management.

Charles Rowland, President & CEO, joined Ohmx in 2011. He brings over 25 years of experience in the healthcare marketplace with both multinational corporations and start-up companies. Prior to joining Ohmx, Mr. Rowland was Chief Executive Officer at Impedance Cardiology Systems (ICS), a research stage medical device company in the heart failure field. Before ICS, from 2001 until 2006, Mr. Rowland was President of Sirtex Medical USA, a liver cancer treatment company, where he started the US operations of the company and rapidly built the business. Prior to Sirtex, Mr. Rowland was a founder and Executive VP with LifeWatch, a cardiac out-patient monitoring service company, from 1991 until it was acquired by CardGuard in 2000. Before LifeWatch, between 1982 and 1991, he held various management positions with Baxter International in their blood therapy and renal businesses.  Mr. Rowland has an MBA from the London Business School and a Bachelor of Science in Economics from Bristol University.

Paul Bao, Ph.D., VP of Product Development, joined Ohmx in 2011 with over 18 years of experience in the IVD industry. From 2002 to 2011, he was Sr. Manager and the Head of Assay Research at Nanosphere Inc., a nanotechnology-based diagnostics company. At Nanosphere Inc. Paul   led a team developing multiple ultra-sensitive protein and DNA assays, including an SNP assay in un-amplified human genomic DNA, which was the first FDA 510(k) cleared genetic test based on nanotechnology. Paul was previously a Manager in the Biochemistry Department, at Corning Inc., working on developing microarray bioassays.  Prior to Corning he was a Sr. Scientist at Vysis (now part of Abbott Laboratories), where he was responsible for the development of a microarray based CGH assays for detecting genetic diseases and cancers. Paul was a Postdoctoral Research Fellow at Dupont-Merck Pharmaceutical where he focused on probe design and ligand-binding assay for drug discovery. Paul holds a Ph.D. in Biochemistry/Molecular Biology from the University of Texas at Austin, a M.S. in Biology from Virginia Tech., and a B.S. in Biology from the Zhejiang University, PRC.

Dimitra Georganopoulou, Ph.D., VP of Research and Development, joined Ohmx in 2005 and has over 14 years of experience in sensors, biosensors and electrochemical biosensors. Specifically, she has background and experience with ion sensors, gas sensors, solvent sensors, glucose sensors for diabetics and head trauma patients, as well as nanoparticle based DNA and protein sensors for the detection of HIV, prostate cancer and Alzheimer's disease. She  has also worked as a consultant for Inverness Medical Technology and Nanosphere, and she is currently heading the Ohmx R&D development of integrated sensors for point-of-care diagnostics and home monitoring. Dimitra was also recently appointed an Adjunct Professor of Chemical and Biological Engineering at Northwestern University. She is the author of numerous peer-reviewed publications and is an expert in the field of analytical electrochemistry, nanotechnology and biotechnology.

Grace Kefer, CPA, Acting Controller, brings to Ohmx over twenty years of experience of financial and administrative management in various industries and also serves as the CEO of Kefer Business Solutions.  A former graduate of Northern Illinois University, Grace took her knowledge and experience from auditing entrepreneurial companies in the public accounting sector, and consulted with clients in the middle market from start-up through sales and acquisition.  Grace was previously with Price Waterhouse and Arthur Anderson and she is currently Acting Controller of Ohmx, overseeing the accounting, administrative and personnel branches.

.

[ back to top ]